Chatbot support for informed consent in research
Official title: Chatbot Implementation In The Clinical Informed Consent Process
Run by M.D. Anderson Cancer Center · NCT07756515 · Data updated 2026-11-12
A chatbot named CoCo is tested to see if it can help patients understand and feel satisfied with the consent process for research studies.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | September 11, 2026 |
| Main results expected | December 17, 2028 |
| Study ends | December 17, 2031 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT07756515 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) who speak English and are being considered for enrollment in selected clinical research studies at UT MD Anderson.
✕Probably not a fit
Patients who do not prefer or have access to digital tools or who require non-English consent may see limited benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests the CoCo chatbot as a remote informed consent tool to see if it improves information delivery and participant comprehension compared with traditional methods. It focuses on adults being considered for enrollment in clinical studies at UT MD Anderson. The primary goal is to assess feasibility, while secondary goals explore acceptance, accuracy of information, process quality, and eligibility verification capability.
Why it matters
Potential benefit: If successful, the chatbot could make informed consent clearer and more convenient for patients.
How similar studies have gone: Previous work with chatbots in consent processes is limited, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ability to understand and willingness to provide informed consent. * Age ≥18 years. * Patients whose preferred language is English. * Patients who are being considered for enrollment in selected clinical research studies. Phase I will be initiated using the Clearinghouse protocol PA11-0852, a non-interventional biomarker study. Exclusion Criteria: N/A
Where it's running
-
UT MD Anderson
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Funda Meric-Bernstam, MD — UT MD Anderson
- Study coordinator: Funda Meric-Bernstam, MD
- Email: fmeric@mdanderson.org
- Phone: (713) 794-1226
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Audio consent with human voice or AI-voice added to written consent for ureteroscopy
This study tests if listening to an audio version of the consent form, read by a real urologist or by an AI-cloned voice, helps adults in Turkey understand their ureteroscopy or RIRS consent better than the written form alone.
-
Consent Understanding and Propofol Use During EBUS
This observational study will see if how well patients understand their consent affects the amount of propofol needed during endobronchial ultrasound (EBUS).
-
Support for Just-In-Time Consent for Prenatal Screening
This study tests a short set of information cards delivered on a phone to help pregnant people decide about prenatal screening.
-
When to get consent for a possible cesarean during labor
This trial tests whether asking patients to sign consent for a possible cesarean when they are admitted to Labor and Delivery, versus only consenting if it becomes clinically likely, improves the childbirth experience for people who plan a vaginal birth but later need an unplanned cesarean.
-
Patient preferences for same-day bilateral eye injections of dexamethasone
This study is trying to see how patients feel about getting eye injections in both eyes on the same day instead of having to come back for separate visits.
-
New consent process for using newborn screening samples in research
This study is testing a new online consent process to see if it helps new mothers better understand and accept how their babies' newborn screening samples can be used for research.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.